Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 403)
Posted On: 06/09/2020 10:20:47 AM
Post# of 36567
Posted By: skipper1072
New BARDA award: AstraZeneca USA
Product Name: AstraZeneca SARS-CoV-2 monoclonal antibody combination
View Announcement


Description:
Support development of a monoclonal antibody combination against SARS-CoV-2


Unique Impact:
A novel monoclonal antibody combination that recognizes and neutralizes SARS-CoV-2 is being developed by AstraZeneca with DARPA and BARDA as a potential preventative and post-exposure treatment to combat COVID-19.


Award Amount: $23,650,000.00


Cost Share: Yes













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site